Category: New products
-
Test of Nasal Skin Cells Found to Detect Lung Cancer
A diagnostic test analyzing the genes in skin cells from nasal passages can detect lung cancer, and the absence of cancer, as accurately as more invasive samples from the airways.
-
Genome Editing Builds Viral Disease Resistance in Pigs
Veterinary researchers used Crispr-Cas9, an emerging genome editing technique, to produce pigs with cells resistant to a common viral disease affecting commercial herds.
-
Handheld Surgical Assist Device in Development
A handheld mechanical device that promises to reduce the cost and ease the work of minimally invasive surgery is being created by a spin-off company from University of Michigan.
-
Smart Watch Data Reveal Epilepsy Triggers
Data collected with Apple smart watches show stress and missed sleep tend to trigger more seizures among people with epilepsy than other causes.
-
Slot Machine Gamblers Get Hooked in Trance-Like State
Findings from a recent study show gamblers who get immersed in playing slot machines are more at risk to develop gambling problems as a result.
-
Stem Cells Launched on Current SpaceX Flight
Yesterday’s SpaceX launch from NASA’s Kennedy Spaceflight Center includes a shipment of adult stem cells to test their growth and proliferation in weightless conditions.
-
Software to Simplify Big Data Curation
A software package in development aims to simplify the process of cleaning up large data sets, known as curation, to improve the quality of analysis from those data.
-
Skin Health Data Collected by App Offered for Research
A smartphone app collecting images and data about moles on the skin of volunteers is now available to researchers for studies of cancer and other disorders.
-
Cancer Drug Shown to Improve Survival Time in Dogs
A drug to treat a deadly cancer in dogs was shown in a clinical trial to extend the survival time of canine patients by 6 months or more, with potential applications in humans.
-
Low-Dose Multidrug Shown Effective in Hypertension Trial
A small-scale clinical trial shows a combination of four current drugs to treat hypertension, or high blood pressure, formulated in low doses, reduces blood pressure to normal levels in four weeks.